Wert202020212022202320242025TTMMittelzufluss aus Investitionstätigkeit-75.51 M-26.74 M4.3 M7.37 M-53.97 M3.56 M-10.23 MZahlungsströme aus der Finanzierungstätigkeit102.37 M-4.68 M-7.62 M-23.27 M-6.57 M-1.15 M590 KFreier Cashflow8.33 M14.63 M13.93 M18.18 M9.56 M14.78 M20.81 M
Simulations Plus, Inc. - Common Stock
Simulations Plus, Inc. develops absorption, distribution, metabolism, excretion, and toxicity modeling and simulation software for the pharmaceutical and biotechnology, industrial chemicals, cosmetics, food ingredients, and herbicide industries. In September 2014, the company acquired Cognigen Corporation, a provider of clinical trial data analysis and consulting services.